Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) (345025)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

The Centers of Biomedical Research Excellence (COBRE) program aims to support the establishment and development of innovative biomedical and behavioral research centers at IDeA-eligible institutions. This is achieved through awards for three sequential five-year phases. The COBRE Phase 2 award focuses on strengthening successful COBRE Phase 1 centers by further improving research infrastructure and continuing the development of a critical mass of investigators with shared scientific interests. These efforts are designed to enhance the investigators' ability to compete effectively for independent research funding, with an emphasis on further improvements to research infrastructure at the institution.

Eligibility

Organization's Location
in commodo
Program Location
qui
Organization Type
up to 1.5M

Submission

Visit Apply for more information.

Similar grants